Purchase Order 75N94022P00756
Award Date
9/1/22
Potential Completion Date
8/31/23
Potential Value
$16K
Funding Federal Agency
National Institute of Diabetes and Digestive and Kidney Diseases
Contracting Federal Agency
National Institute of Child Health and Human Development
Awardee
Imquest Biosciences, Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21704, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $88,000 firm fixed price purchase order to Frontage Laboratories, Inc., a full-service contract research organization, to provide specialized pharmacokinetic and metabolism research services. The contract supports NIDDK's efforts to advance the testing of a new class of antiviral molecules by conducting blood stability studies, rat and mouse pharmacokinetic studies, and in vitro hepatocyte metabolism studies...
This federal contract award, with an ID of HHSN275201600364P, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Mybiosource Inc., a woman-owned small business, on May 3, 2016. The contract has a firm fixed price of $3,740.00 and a completion date of July 2, 2016. The contract was not set aside for any specific business designation. The contract is for the purchase of products or services related to the work of NIDDK, though the...
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (HHS-NIH-NIDDK) awarded a $20,000 purchase order contract to Immunochemistry Technologies, LLC of Bethesda, Maryland for assay optimization services. The firm fixed price contract runs from August 5, 2016 through September 30, 2016 for optimization of assays, presumably to support NIDDK's research efforts related to diabetes, digestive diseases, and kidney...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $243,264 firm fixed price purchase order contract to Bioqual, Inc. to provide laboratory analysis services for NIDDK mice studies. The contract, which runs from September 2023 through September 2027 in Potomac, Maryland, was awarded through a solicitation seeking acquisition of such services to support...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Imquest Biosciences, Inc. for $72,000.00. The order was not set aside for any specific business category. The ultimate completion date was September 30, 2017. Imquest Biosciences, Inc. is a preclinical contract research and development organization that provides services to evaluate the potential of new...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $37,000.00 Firm Fixed Price purchase order to Polyorg, Inc., a for-profit manufacturer located in Leominster, Massachusetts. The contract is for the procurement of Bhoc Nucleobase Acids to support NIDDK's biomedical research. This award was made without competition under the original Request for Quotation (RFQ) number 75N94023Q00088, which had a NAICS code of 541380 with a $19 million size standard. No...
This is a $20,960 fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to the JAI Research Foundation, a non-profit organization. The contract is for solubility, stability, and toxicology studies to advance novel drug candidates developed by the NIDDK into clinical trials. This contract was awarded on September 25, 2020 and has a completion date of September 24, 2021. The contract stems from a small...
The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $10,848.60 firm fixed-price purchase order contract to Life Technologies Corporation of Grand Island, New York. As the prime contractor, Life Technologies Corporation will provide unspecified products or services to the agency between March 15, 2019 and April 14, 2019 to support the National Institute of Diabetes and Digestive and Kidney...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $24,948 purchase order to Phoenixbio Co., LTD. of Japan. The firm fixed price contract is for the delivery of 18 plates of 24-well plates containing PXBCELLS to support NIDDK research efforts. The one year contract runs from September 2, 2023 through September 1, 2024 and will be performed in...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded a $227,011.68 delivery order contract to Inode Ink Corporation Khai Huynh Division. This order was issued against the Chief Information Officer - Solutions and Partners 3 Small Business Government-Wide Acquisition Contract (CIO-SP3 SB GWAC) for the purpose of providing Infrastructure System...